Harvard Bioscience, Inc. (HBIO) vs Regentis Biomaterials Ltd. (RGNT)
Harvard Bioscience, Inc. and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. Harvard Bioscience, Inc. is the larger, with a market value of $36.5M against $15.8M — 2.3× the size. Across the 9 metrics below, Regentis Biomaterials Ltd. leads on 8 and Harvard Bioscience, Inc. on 1.
Valuation
Profitability
| Metric | HBIO | RGNT | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 58.16% | — | 54.62% |
| Operating margin | (0.28%) | — | 1.64% |
| Net margin | (11.86%) | — | 0.00% |
| Free cash flow margin | (2.09%) | 0.00% | 1.61% |
| Return on equity | (89.95%) | 0.00% | 0.00% |
| Return on assets | (13.32%) | 0.00% | 0.00% |
| Return on invested capital | (0.41%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack